US Pricing Reform Puts Cancer Drug Innovation At Risk, Drug Leaders Warn

 
• By Jessica Merrill
  
Galien CEO Panel
Industry leaders discussed impacts of the IRA at the Galien Forum • Source: Galien
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip